Stay updated on AGN-241751 Efficacy in Major Depression Clinical Trial
Sign up to get notified when there's something new on the AGN-241751 Efficacy in Major Depression Clinical Trial page.

Latest updates to the AGN-241751 Efficacy in Major Depression Clinical Trial page
- Check2 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, indicating a new release; the 'Back to Top' link was removed as a minor UI change.SummaryDifference0.6%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.7%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference31%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check38 days agoChange DetectedThe page has updated the company name from Gate Neurosciences, Inc to Syndeio Biosciences, Inc and has also changed the version number from v2.16.10 to v2.16.11.SummaryDifference2%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to AGN-241751 Efficacy in Major Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AGN-241751 Efficacy in Major Depression Clinical Trial page.